Email this article Application of autonomous extended infusion therapy systems in treatment of patients with hemoblastoses. Experience of the Oncohematology Division of the Clinical Hospital “Lapino”
- Authors: Ryabukhina Y.E.1, Zeynalova P.A.1,2, Abbasbeyli F.M.1, Timofeeva O.L.1, Valiev T.T.2, Zhukov A.G.1, Kupryshina N.A.3
-
Affiliations:
- Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
- Issue: Vol 3, No 1 (2023)
- Pages: 61-67
- Section: RARE COMPLICATIONS, QUALITY OF LIFE, AND FOLLOW-UP CARE OF ONCOHEMATOLOGICAL PATIENTS
- Published: 15.03.2023
- URL: https://mdonco.abvpress.ru/jour/article/view/65
- DOI: https://doi.org/10.17650/2782-3202-2023-3-1-61-67
- ID: 65
Cite item
Full Text
Abstract
Use of microinfusion elastomeric pumps for extended administration of antitumor drugs improves patients’ quality of life during prolonged cyclic treatment because of the absence of venous complications and infusion allergic reactions during administration of cytostatic agents and targeted drugs.
About the authors
Yu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Author for correspondence.
Email: gemonk.yur@mail.ru
ORCID iD: 0000-0001-8443-8816
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationP. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0003-1564-424X
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationF. M. Abbasbeyli
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-2359-0547
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationO. L. Timofeeva
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-6229-7300
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationT. T. Valiev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0002-1469-2365
Bld. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationA. G. Zhukov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0001-5353-8857
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationN. A. Kupryshina
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
ORCID iD: 0000-0001-8509-0954
24 Kashirskoe Shosse, Moscow 115478
Russian FederationReferences
- Kreidieh F.Y., Moukadem H.A., El Saghir N.S. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016;7(1):87–97. doi: 10.5306/wjco.v7.i1.87
- Skryabina E.A., Dunn T.S. Disposable infusion pumps. Am J Health Syst Pharm 2006;63(13):1260–8. doi: 10.2146/ajhp050408
- Evans J.M., Qiu M., MacKinnon M. et al. A multi-method review of home-based chemotherapy. Eur J Cancer Care (Engl) 2016;25(5):883–902. doi: 10.1111/ecc.12408
- Giuliano K.K., Penoyer D., Mahuren R.S., Bennett M. Intravenous smart pumps during actual clinical use: a descriptive comparison of primary and secondary infusion practices. J Infus Nurs 2021;44(3):128–36. doi: 10.1097/NAN.0000000000000415
- Mann J.R., Abrams L.D., Deeble T.J., Stuart J. Prolonged intermittent cytotoxic therapy in children using a microinfusion pump. Lancet 1970;2(7683):1116–7. doi: 10.1016/s0140-6736(70)92301-9
- Yu C.H., Jou S.T., Su Y.H. et al. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia. Cancer 2023;129(5):790–802. doi: 10.1002/cncr.34606
- Robinson H.R., Qi J., Cook E.M. et al. A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood 2018;132(5):521–32. doi: 10.1182/blood-2018-02-830992
- Locatelli F., Zugmaier G., Rizzari C. et al. Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial. Jama 2021;325(9):843–54. doi: 10.1001/jama.2021.0987
- Abdurakhmanov D.T., Abuzarova G.R., Ageeva T.A. et al. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Ed. by I.V. Poddubnaya, V.G. Savchenko. Moscow, 2018. 470 p. (In Russ.).
- Buidenok Yu.V. Recommendations for the prevention and treatment of the effects of extravasation of antitumor drugs. Prakticheskiye rekomendatsii RUSSCO = Malignant tumours: Practical recommendations of RUSSCO 2021;11(3s2):156–66. (In Russ.). doi: 10.18027/2224-5057-2021-11-3s2-48
- Babicheva L.G., Tumyan G.S., Osmanov E.A. et al. Follicular lymphoma. Sovremennaya oncologiya = Journal of Modern Oncology 2020;22(2):34–51. doi: 10.26442/18151434.2020.2.200131
- Dimopoulos M.A., Moreau P., Terpos E. et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32(3):309–22. doi: 10.1016/j.annonc.2020.11.014
Supplementary files
